The new service is available at over 30 Hong Kong clinics and clinic groups at the launch stage to provide speedy and accurate delivery of prescription medicine to patients' homes. The service is operated by S.F. Express (Hong Kong) Limited ("SFHK") in collaboration with Kerry Pharma, the pharmaceutical business division of Kerry Logistics Network.
"In the current outbreak in Hong Kong, many patients are confined to their homes and receiving doctors' consultation virtually. There are also chronic patients who are unable to get their prescriptions without going out," said Tony Cheng, Head of Commercial Hong Kong and Macau of Merck Pharmaceutical (HK) Limited. "As a pharmaceutical company, we see the need for a reliable and professional delivery service for patients' medication to help them maintain their health. The service provided by Kerry Pharma and SFHK, with their respective expertise in pharmaceutical logistics and professional express delivery, is one that we can trust to help our clinic clients and their patients."
Phoebe Mo, General Manager of Kerry Pharma (Hong Kong), said, "We have recently launched the Medication Home Delivery service in collaboration with SFHK for medical groups, pharmaceutical companies as well as community pharmacies of local NGOs. We are eager to put our decade-long experience in pharmaceutical logistics to good use by serving Merck HK and its associated private clinics and clinic groups, thus helping more patients in need. Our Good Distribution Practice (GDP) certification and experienced quality assurance team mean that we can ensure the medication delivery is safe and secure."
Keith Ip, Chief Marketing Officer of S.F. Express (Hong Kong) Limited said, "By further utilizing our existing resources through the provision of the Medication Home Delivery service with Merck HK to a broader group of medical institutions, we can do more in aid of the community and support even more patients. With our established local logistics network and trusted delivery team, we can provide efficient and reliable same-day deliveries that patients can monitor to help put their minds at ease."
Merck, a leading science, and technology company, operates across healthcare, life science and electronics. Around 58,000 employees work to make a positive difference to millions of people's lives every day by creating more joyful and sustainable ways to live. From advancing gene editing technologies and discovering unique ways to treat the most challenging diseases to enabling the intelligence of devices – the company is everywhere. In 2020, Merck generated sales of €17.5 billion in 66 countries. Scientific exploration and responsible entrepreneurship have been key to Merck's technological and scientific advances. This is how Merck has thrived since its founding in 1668. The founding family remains the majority owner of the publicly listed company. Merck holds the global rights to the Merck name and brand. The only exceptions are the United States and Canada, where the business sectors of Merck operate as EMD Serono in healthcare, MilliporeSigma in life science, and EMD Electronics.
The issuer is solely responsible for the content of this announcement.